Last updated on May 2009

Study of Weekly ALTU-238 Compared With Daily Nutropin AQ in Prepubertal Children With Growth Hormone Deficiency

Brief description of study

The purpose of the study is to evaluate the safety and effectiveness of ALTU-238 in the treatment of children with growth hormone deficiency who have not yet reached puberty who lack the normal ability to make growth hormone themselves. This study will also test if ALTU-238 works as a weekly treatment.

Clinical Study Identifier: NCT00837863

Find a site near you

Start Over

Schneider Children's Hospital

New Hyde Park, NY United States
  Connect »